Sales of Johnson & Johnson’s diabetes drug Invokana have suffered since the FDA put a warning in the box on the label describing the product’s amputation risks. But in a nutshell, the bureau now says this warning has been removed. The FDA this week scrapped the warning in the box …
Read More »FDA pulls J & J’s Invokana alert in boxes after reviewing amputation risks – but sales damage done
